Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04044456 |
Other study ID # |
N3189-P |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 1, 2019 |
Est. completion date |
December 31, 2022 |
Study information
Verified date |
May 2023 |
Source |
VA Office of Research and Development |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Veterans with mild traumatic brain injury continue to deal with symptoms that interfere with
their ability to engage in productive activities. In combination with other psychosocial
difficulties, impairments are found in cognition, such as attention and executive function.
Few interventions are available to treat attention in Veterans with mTBI. Of the
interventions available, none rigorously train attention combined with strategy training.
This project will innovatively combine a strategy training called Goal Management Training
with computerized attention training to improve tests of problem solving, attention and
functional tasks compared to a control group.
Description:
This is a pilot study to test the effect of GMT plus Attention Training for Veterans with
chronic mTBI. The research design is a parallel study with randomization to treatment or
control with test administration at pre/post and six months following treatment. The
investigators will enroll 50 Veterans with a diagnosis mTBI between the ages of 18 to 55,
that demonstrate a deficit in attention, pass effort testing and have not changed
psychotropic medication within the past two weeks. Treatment utilizes GMT for 10-weekly
two-hour sessions and Brain HQ/Attention Process Training III for 10-weekly two-hour
sessions. Control utilizes a complimentary Brain Health Workshop for 10-weely two-hour
sessions and National Geographic movies for 10-weekly two-hour sessions.
Aim 1: Determine the treatment effect of attention training combined with GMT in Veterans
with mTBI.
Hypothesis 1: GMT plus attention training will significantly improve performance on tests of
cognition compared to the control group.
Primary measure: Computerized Tower of London (cTOL) total time, time to first move and
optimal moves). The investigators have found significant improvement in cTOL following GMT in
previous cohorts of Veterans with blast-related mTBI and anticipate improvement following a
combined intervention.
Secondary measure: Attention Network Task (ANT) reaction time and errors for one or all
dissociable components of three attentional systems (orienting, alerting, executive control)
following intervention. There is little understanding of components of impaired attention and
how it impacts executive function; therefore, there is limited guidance in shaping cognitive
training. The investigators will conduct an experimental task (attention network task) that
disassociates three attentional components (alerting, orienting, and executive control). The
investigators will specifically target the orienting component of attention that is
problematic for Veterans with mTBI and PTSD24, 26. Attentional processes are vital to
goal-directed behavior. There is great potential in the use of these measures to identify
individual differences (type of attention deficit) that could moderate treatment-related
improvement and inform targeted interventions.
Hypothesis 2: Treatment gains will translate to functional activities compared to controls.
Primary measure of functional performance: test of grocery shopping skills (TOGSS) total time
and optimal strategy use. The TOGSS captures efficiency in completing a real-world task and
aligns with the strategy skills learned in GMT.
Secondary measure of community participation, the Community Reintegration of Servicemembers
(CRIS) extent of participation. The CRIS demonstrated significant GMT treatment effect
compared to controls in Veterans with mTBI. The combined treatment of attention training
using drill training and implementing strategies to improve attention in a functional setting
through GMT will potentiate treatment effect to functional activities. Measuring functional
improvement through performance-based measures and self-report of engagement in activities
will demonstrate treatment translation.
Tertiary analysis will be conducted on moderator variables: PTSD symptoms, Pain, History of
Substance Abuse, Depression, number of concussions and combat exposure.
Successful completion of the proposed study will provide insight into the effectiveness of
the innovative combined treatment of attention and executive function in Veterans with mTBI
and PTSD. Use of the ANT could better target treatment and lead to future examination of
attention treatment on neuroplasticity.
A multiple linear regression model will be used to determine if there is a significant
association between treatment effect and comorbidities such as PTSD, depression, anxiety,
pain, sleep, substance abuse, etc.